Eric Lacoste

Eric Lacoste

Company: Sanofi

Job title: Head of ADC Conjugation Development/Global CMC Development


Panel Discussion – Optimizing Conjugation Processes to Decrease Heterogeneity & Prepare for Scale-Up 2:30 pm

Understanding the quantity of mAb fragments which must be removed and what can be dosed in small amounts Considering the conjugation technology and conditions used as well as their upscale applications Creating a platform to increase conjugation yieldRead more

day: Day One

Transforming Conjugation Processes to Optimize ADC Homogeneity 9:00 am

The conjugation process is one of the key determinants in ensuring the homogeneity and stability of your ADC throughout its process development journey. With the ADC world ever-expanding, technologies that ensure a robust conjugation process with a high yield are of utmost importance. Considering the increasing competition to get ADCs into the clinic, creating a…Read more

day: Pre-Conference Workshop Day

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.